Psychiatry & Neurology, Clinical Neurophysiology · Crestview Hills, KY
NPI
1205037470
Since 2007
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2670 Chancellor Drive
Crestview Hills, KY, 41017
Phone (859) 957-0052
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
738 services
Medicare patients, 2024
362
Average age 72
Drug cost, 2024
$994K
2,801 prescriptions
Company payments, 2025
$684
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ty Brown was code 99232 (hospital e&m - subsequent), 185 times for 95 patients. In total Ty Brown billed 738 services in 25 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 185 | 95 | $60.63 | $11K |
| 99223 Hospital E&M - Initial | Facility | 126 | 125 | $130.65 | $16K |
| 99214 Office E&M - Established | Office | 108 | 103 | $74.94 | $8,093 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 101 | 98 | $11.20 | $1,131 |
| 95816 Neurologic | Facility | 47 | 47 | $40.20 | $1,889 |
| 99233 Hospital E&M - Subsequent | Facility | 30 | 17 | $88.53 | $2,656 |
| 99204 Office E&M - New | Office | 23 | 23 | $106.01 | $2,438 |
| 95717 Neurologic | Facility | 19 | 18 | $80.51 | $1,530 |
| 99213 Office E&M - Established | Office | 16 | 13 | $47.44 | $759 |
| 99215 Office E&M - Established | Office | 15 | 15 | $109.76 | $1,646 |
| 95723 Neurologic | Facility | 13 | 13 | $151.05 | $1,964 |
| 95813 Neurologic | Facility | 11 | 11 | $59.13 | $650 |
By year: 2022 $64K for 741 services; 2023 $65K for 750 services; 2024 $55K for 738 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ty Brown prescribed most often to Medicare patients was Levetiracetam, with 266 prescriptions and refills. In total Ty Brown wrote 2,801 Medicare prescriptions that cost $994K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 266 | 467 | 56 | $12K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 157 | 321 | 37 | $5,987 |
| Lacosamide Generic | 145 | 166 | 16 | $18K |
| Primidone Generic | 144 | 257 | 29 | $2,528 |
| Gabapentin Generic | 143 | 186 | 27 | $1,871 |
| Donepezil Hcl Generic | 141 | 306 | 40 | $1,136 |
| Topiramate Generic | 141 | 240 | 23 | $2,263 |
| Lamotrigine Generic | 140 | 256 | 22 | $2,803 |
| Memantine Hcl Generic | 112 | 176 | 23 | $1,811 |
| Xcopri Cenobamate | 99 | 99 | 11 | $101K |
| Divalproex Sodium Er Divalproex Sodium | 87 | 111 | 17 | $6,168 |
| Clonazepam Generic | 68 | 70 | Under 11 | $395 |
| Pregabalin Generic | 66 | 76 | Under 11 | $3,883 |
| Duloxetine Hcl Generic | 58 | 102 | Under 11 | $1,966 |
| Clobazam Generic | 56 | 58 | Under 11 | $4,285 |
Brand drugs: 422 claims; generic drugs: 2,352 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ty Brown $684 ($684 in general payments such as food, travel and fees) from 14 companies. The largest payer was Amneal Pharmaceuticals LLC with $207.
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC AMRX | 11 | $207 |
| Jazz Pharmaceuticals Inc. JAZZ | 5 | $88.81 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $58.62 |
| TG Therapeutics, Inc. TGTX | 2 | $46.02 |
| Abbvie Inc. ABBV | 2 | $41.44 |
| UCB, Inc. UCB.BR | 2 | $38.44 |
| Ceribell, Inc. CBLL | 1 | $35.2 |
| Lilly USA, LLC LLY | 2 | $34.79 |
| SK Life Science, Inc. | 1 | $33.36 |
| EMD Serono, Inc. MRK.DE | 1 | $26.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.